Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

Jorge Saucedo

Concepts (378)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Acute Coronary Syndrome
26
2026
107
4.290
 Why?
Angioplasty, Balloon, Coronary
40
2020
168
4.270
 Why?
Myocardial Infarction
31
2023
445
3.830
 Why?
Platelet Aggregation Inhibitors
31
2020
213
3.540
 Why?
Registries
44
2026
652
2.630
 Why?
Percutaneous Coronary Intervention
20
2020
329
2.450
 Why?
Coronary Artery Disease
17
2026
324
2.160
 Why?
Stents
21
2020
376
1.920
 Why?
Ticlopidine
16
2016
71
1.600
 Why?
Risk Assessment
20
2019
1368
1.300
 Why?
Electrocardiography
11
2016
273
1.290
 Why?
Hospital Mortality
17
2020
457
1.210
 Why?
Hemorrhage
14
2018
226
1.180
 Why?
Coronary Angiography
19
2020
369
1.160
 Why?
Myocardial Revascularization
9
2017
29
1.060
 Why?
Platelet Glycoprotein GPIIb-IIIa Complex
12
2012
46
1.060
 Why?
Drug-Eluting Stents
7
2020
101
1.050
 Why?
Coronary Disease
13
2007
144
1.040
 Why?
Hirudins
7
2016
23
1.030
 Why?
Coronary Restenosis
7
2020
39
1.010
 Why?
Aged
76
2026
10429
1.010
 Why?
Peptide Fragments
7
2016
209
0.960
 Why?
Anticoagulants
12
2015
280
0.950
 Why?
Thiophenes
8
2014
45
0.940
 Why?
Middle Aged
76
2026
13419
0.910
 Why?
Time Factors
29
2020
2991
0.890
 Why?
Piperazines
8
2014
125
0.890
 Why?
Treatment Outcome
51
2023
5595
0.870
 Why?
Peptides
8
2010
234
0.850
 Why?
Male
87
2026
27435
0.810
 Why?
Purinergic P2Y Receptor Antagonists
6
2016
35
0.810
 Why?
Cardiac Catheterization
12
2021
229
0.800
 Why?
Platelet Aggregation
9
2014
77
0.790
 Why?
Sirolimus
5
2013
72
0.780
 Why?
Guideline Adherence
7
2026
143
0.780
 Why?
Postoperative Complications
8
2020
1099
0.770
 Why?
Coronary Vessels
6
2017
170
0.770
 Why?
Myocardial Ischemia
7
2010
129
0.760
 Why?
Humans
114
2026
53230
0.750
 Why?
Female
84
2026
28782
0.750
 Why?
Coronary Artery Bypass
10
2015
134
0.740
 Why?
Cardiovascular Agents
4
2026
66
0.730
 Why?
Risk Factors
29
2020
4017
0.700
 Why?
Practice Guidelines as Topic
11
2026
502
0.700
 Why?
Fibrinolytic Agents
5
2020
132
0.640
 Why?
Heart Transplantation
4
2015
327
0.640
 Why?
Thrombosis
6
2014
250
0.620
 Why?
Drug Substitution
3
2014
15
0.600
 Why?
United States
27
2021
5409
0.600
 Why?
Retrospective Studies
27
2020
6819
0.580
 Why?
Follow-Up Studies
17
2019
2318
0.560
 Why?
Aged, 80 and over
24
2021
3494
0.540
 Why?
Myocardial Reperfusion
3
2015
13
0.540
 Why?
Saphenous Vein
2
2015
63
0.510
 Why?
Angina, Unstable
7
2006
25
0.500
 Why?
Heparin, Low-Molecular-Weight
2
2016
22
0.490
 Why?
Tyrosine
3
2004
92
0.460
 Why?
Renal Insufficiency, Chronic
3
2013
205
0.460
 Why?
Immunosuppressive Agents
5
2013
253
0.450
 Why?
Coronary Sinus
1
2015
5
0.450
 Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
4
2017
146
0.440
 Why?
Anastomosis, Surgical
1
2015
69
0.440
 Why?
Metals
2
2012
37
0.430
 Why?
Inpatients
3
2019
208
0.430
 Why?
Heart Valve Prosthesis
3
2021
89
0.430
 Why?
Prospective Studies
16
2021
2411
0.420
 Why?
Patient Admission
1
2014
81
0.420
 Why?
Heart Valve Prosthesis Implantation
3
2021
103
0.410
 Why?
Evidence-Based Medicine
7
2012
275
0.410
 Why?
Recombinant Proteins
8
2016
489
0.400
 Why?
Blood Platelets
6
2014
247
0.400
 Why?
Aspirin
7
2015
123
0.380
 Why?
Hemoglobins
1
2013
114
0.370
 Why?
Cardiology
3
2021
106
0.360
 Why?
Survival Rate
9
2017
949
0.360
 Why?
Severity of Illness Index
7
2018
1049
0.350
 Why?
Diabetes Mellitus, Type 1
1
2014
224
0.350
 Why?
Aorta
1
2012
172
0.350
 Why?
Mitral Valve
3
2020
57
0.340
 Why?
Blood Vessel Prosthesis Implantation
2
2012
135
0.340
 Why?
Aortic Aneurysm, Abdominal
1
2011
52
0.330
 Why?
Mitral Valve Annuloplasty
2
2021
6
0.330
 Why?
Diabetes Mellitus, Type 2
2
2014
591
0.320
 Why?
Mesenteric Artery, Superior
1
2010
12
0.320
 Why?
Ischemic Attack, Transient
2
2020
59
0.310
 Why?
Bioprosthesis
2
2021
41
0.300
 Why?
Angioplasty, Balloon
1
2010
69
0.300
 Why?
Thrombectomy
1
2010
74
0.300
 Why?
Stroke
4
2020
520
0.300
 Why?
Prosthesis Design
6
2021
266
0.300
 Why?
Kidney Diseases
1
2011
230
0.290
 Why?
Patient Discharge
5
2018
325
0.290
 Why?
Prosthesis Failure
2
2020
113
0.280
 Why?
Immunoglobulin Fab Fragments
3
2004
19
0.280
 Why?
Intracranial Hemorrhages
2
2019
44
0.280
 Why?
American Heart Association
2
2021
44
0.280
 Why?
Postoperative Hemorrhage
1
2008
54
0.280
 Why?
Chi-Square Distribution
6
2014
291
0.260
 Why?
Secondary Prevention
2
2026
85
0.260
 Why?
Odds Ratio
6
2014
567
0.250
 Why?
Prognosis
9
2019
2118
0.250
 Why?
Stroke Volume
3
2019
150
0.250
 Why?
Antibodies, Monoclonal
4
2004
477
0.240
 Why?
Cardiovascular Diseases
2
2021
501
0.230
 Why?
Peripheral Arterial Disease
2
2019
84
0.230
 Why?
Internal Mammary-Coronary Artery Anastomosis
1
2005
5
0.230
 Why?
Mammary Arteries
1
2005
10
0.230
 Why?
Incidence
7
2019
1085
0.230
 Why?
Comorbidity
5
2015
638
0.220
 Why?
Ventricular Function, Left
2
2019
178
0.220
 Why?
Intermittent Claudication
3
2014
16
0.220
 Why?
Antithrombins
3
2016
22
0.220
 Why?
Heparin
1
2005
86
0.220
 Why?
Coronary Stenosis
1
2005
99
0.210
 Why?
Heart Valve Diseases
2
2020
55
0.210
 Why?
Diabetes Mellitus
3
2023
321
0.200
 Why?
Platelet Function Tests
5
2014
22
0.200
 Why?
Vascular Diseases
2
2015
75
0.190
 Why?
Logistic Models
7
2014
947
0.190
 Why?
Administration, Oral
4
2013
456
0.190
 Why?
Shock, Cardiogenic
2
2018
35
0.190
 Why?
Aryl Hydrocarbon Hydroxylases
2
2013
75
0.190
 Why?
Double-Blind Method
7
2014
729
0.190
 Why?
Aortic Valve
2
2019
130
0.190
 Why?
Angiotensin Receptor Antagonists
2
2019
22
0.180
 Why?
Angiotensin-Converting Enzyme Inhibitors
2
2019
73
0.180
 Why?
Drug Therapy, Combination
5
2015
405
0.180
 Why?
Research Report
1
2021
19
0.170
 Why?
Receptors, Purinergic P2Y12
4
2013
17
0.170
 Why?
Recurrence
8
2018
694
0.170
 Why?
Ethics, Medical
1
2021
46
0.170
 Why?
Adrenergic beta-Antagonists
2
2018
108
0.170
 Why?
Patient Selection
7
2016
273
0.160
 Why?
Syndrome
6
2007
248
0.160
 Why?
Cardiac Catheters
1
2020
12
0.160
 Why?
Influenza, Human
1
2021
88
0.160
 Why?
Creatine Kinase
1
2000
31
0.160
 Why?
Hemostatic Techniques
3
2009
32
0.160
 Why?
Hospitalization
7
2016
749
0.160
 Why?
Angioplasty
1
2000
21
0.160
 Why?
Multivariate Analysis
7
2016
598
0.160
 Why?
Calcinosis
1
2020
53
0.150
 Why?
Renin-Angiotensin System
1
2019
58
0.150
 Why?
Cohort Studies
6
2018
1557
0.140
 Why?
Databases, Factual
4
2019
742
0.140
 Why?
Aortic Valve Stenosis
1
2019
79
0.140
 Why?
Feasibility Studies
2
2026
411
0.140
 Why?
Cell Adhesion Molecules
3
2013
88
0.130
 Why?
Decision Support Techniques
1
2018
73
0.130
 Why?
Mitral Valve Insufficiency
1
2018
56
0.130
 Why?
Blood Coagulation
3
2014
65
0.130
 Why?
Graft Occlusion, Vascular
2
2012
81
0.130
 Why?
Neoplasms
2
2017
1334
0.130
 Why?
Adult
11
2015
14534
0.130
 Why?
Exercise Tolerance
2
2014
43
0.120
 Why?
Microfilament Proteins
2
2013
44
0.120
 Why?
Brachytherapy
3
2002
51
0.120
 Why?
Europe
4
2018
91
0.120
 Why?
Glomerular Filtration Rate
2
2013
128
0.120
 Why?
Radiography
4
2011
476
0.120
 Why?
Consensus
3
2021
206
0.120
 Why?
Research Design
2
2016
373
0.120
 Why?
Predictive Value of Tests
5
2018
934
0.110
 Why?
Phosphoproteins
2
2013
117
0.110
 Why?
Troponin
2
2012
16
0.110
 Why?
Creatine Kinase, MB Form
2
2012
10
0.110
 Why?
Heart Diseases
2
2012
221
0.110
 Why?
Vitamin K
1
2014
17
0.110
 Why?
Genotype
2
2014
563
0.110
 Why?
Holidays
1
2014
4
0.110
 Why?
Warfarin
1
2015
81
0.110
 Why?
Morbidity
1
2014
132
0.100
 Why?
Phenotype
2
2014
803
0.100
 Why?
Gene Transfer Techniques
2
2003
44
0.100
 Why?
Atrial Fibrillation
1
2015
197
0.100
 Why?
Statistics, Nonparametric
1
2013
198
0.100
 Why?
Drug Prescriptions
1
2013
116
0.090
 Why?
Aortography
1
2012
33
0.090
 Why?
Pharmacogenetics
1
2012
52
0.090
 Why?
Adenosine Monophosphate
1
2012
14
0.090
 Why?
Dose-Response Relationship, Drug
1
2016
1367
0.090
 Why?
Quinazolinones
1
2012
7
0.090
 Why?
Kidney Function Tests
1
2012
55
0.090
 Why?
Pyridines
1
2013
135
0.090
 Why?
Chronic Disease
2
2011
580
0.090
 Why?
Femoral Artery
3
2009
106
0.090
 Why?
Drug Delivery Systems
2
2005
148
0.090
 Why?
Quality Indicators, Health Care
1
2012
92
0.090
 Why?
Propensity Score
3
2019
170
0.090
 Why?
Bundle-Branch Block
1
2011
18
0.090
 Why?
Diabetes Complications
2
2002
124
0.090
 Why?
Emergency Service, Hospital
2
2013
530
0.090
 Why?
Aortic Rupture
1
2011
19
0.090
 Why?
Randomized Controlled Trials as Topic
5
2009
630
0.090
 Why?
Disease-Free Survival
5
2011
466
0.090
 Why?
Transportation of Patients
1
2011
39
0.090
 Why?
Hospitals
1
2012
181
0.090
 Why?
Sulfonamides
1
2012
139
0.080
 Why?
Diagnostic Imaging
1
2012
176
0.080
 Why?
Diabetic Angiopathies
1
2011
23
0.080
 Why?
Algorithms
2
2008
667
0.080
 Why?
Ischemia
1
2011
158
0.080
 Why?
Transplantation, Homologous
1
2011
154
0.080
 Why?
Prevalence
4
2019
1034
0.080
 Why?
Graft Survival
1
2011
157
0.080
 Why?
Patient Care Team
1
2012
278
0.080
 Why?
Drug Administration Schedule
4
2014
370
0.080
 Why?
Health Services Accessibility
1
2014
477
0.080
 Why?
Fluoroscopy
1
2009
49
0.080
 Why?
Clinical Trials as Topic
3
2008
466
0.080
 Why?
Adolescent
3
2012
6907
0.070
 Why?
Genetic Vectors
2
2007
127
0.070
 Why?
Radiography, Interventional
1
2009
58
0.070
 Why?
Acute Disease
4
2014
393
0.070
 Why?
Palliative Care
1
2011
195
0.070
 Why?
Preoperative Care
2
2012
173
0.070
 Why?
Thrombelastography
1
2009
27
0.070
 Why?
Endovascular Procedures
1
2011
193
0.070
 Why?
Multicenter Studies as Topic
4
2017
114
0.070
 Why?
Emergency Treatment
1
2008
29
0.070
 Why?
Asia
2
2018
24
0.070
 Why?
Analysis of Variance
3
2009
547
0.070
 Why?
Age Factors
4
2018
1136
0.070
 Why?
Peripheral Vascular Diseases
1
2007
22
0.060
 Why?
Equipment Design
3
2020
290
0.060
 Why?
Plasmids
1
2007
164
0.060
 Why?
Kidney Failure, Chronic
1
2009
210
0.060
 Why?
International Cooperation
2
2016
52
0.060
 Why?
Mexico
1
2026
38
0.060
 Why?
Thrombolytic Therapy
2
2004
114
0.060
 Why?
Young Adult
2
2012
4511
0.060
 Why?
Canada
2
2018
112
0.060
 Why?
Carrier Proteins
1
2007
315
0.060
 Why?
Coronary Vessel Anomalies
1
2005
37
0.060
 Why?
Iridium Radioisotopes
2
2002
5
0.060
 Why?
Quality of Health Care
1
2006
189
0.050
 Why?
Tennessee
1
2004
37
0.050
 Why?
Mississippi
1
2004
90
0.050
 Why?
Bradycardia
1
2004
38
0.050
 Why?
Infusions, Intravenous
1
2004
211
0.050
 Why?
Endothelial Growth Factors
1
2003
11
0.050
 Why?
Lymphokines
1
2003
20
0.050
 Why?
Oklahoma
2
2014
24
0.050
 Why?
Thrombocytopenia
1
2004
89
0.050
 Why?
Enoxaparin
1
2003
32
0.050
 Why?
Intercellular Signaling Peptides and Proteins
1
2003
107
0.050
 Why?
Neovascularization, Physiologic
1
2003
86
0.050
 Why?
Coated Materials, Biocompatible
1
2002
34
0.050
 Why?
Point-of-Care Systems
1
2003
68
0.050
 Why?
Paclitaxel
1
2002
91
0.050
 Why?
Platelet Activation
2
2013
48
0.050
 Why?
Thalidomide
1
2004
378
0.050
 Why?
Tissue Adhesives
1
2001
15
0.040
 Why?
Latin America
1
2021
11
0.040
 Why?
Cell Cycle
1
2002
237
0.040
 Why?
Angioplasty, Laser
1
2001
1
0.040
 Why?
Heptanoic Acids
1
2000
35
0.040
 Why?
Anticholesteremic Agents
1
2000
31
0.040
 Why?
Punctures
3
2009
52
0.040
 Why?
Pulmonary Edema
1
2000
15
0.040
 Why?
Walking
2
2014
106
0.040
 Why?
Quality of Life
2
2007
902
0.040
 Why?
Pyrroles
1
2000
73
0.040
 Why?
Regression Analysis
2
2016
391
0.040
 Why?
Yttrium Radioisotopes
1
2000
9
0.040
 Why?
Atherectomy, Coronary
1
1999
5
0.040
 Why?
Arterial Occlusive Diseases
1
1999
85
0.040
 Why?
Vaccination
1
2021
310
0.040
 Why?
Cause of Death
1
2019
156
0.040
 Why?
Tissue Plasminogen Activator
1
1999
108
0.040
 Why?
Gender Identity
1
2018
30
0.030
 Why?
Brazil
1
2018
39
0.030
 Why?
Intra-Aortic Balloon Pumping
1
2018
6
0.030
 Why?
Echocardiography, Doppler, Color
1
2018
21
0.030
 Why?
Sweden
1
2018
11
0.030
 Why?
Length of Stay
1
2001
684
0.030
 Why?
Arkansas
1
2004
2068
0.030
 Why?
Hypolipidemic Agents
1
1998
30
0.030
 Why?
Erythrocyte Transfusion
1
2018
53
0.030
 Why?
Administration, Intravenous
1
2018
73
0.030
 Why?
South America
1
2017
4
0.030
 Why?
Echocardiography, Transesophageal
1
2018
63
0.030
 Why?
Cardiotonic Agents
1
2018
70
0.030
 Why?
North America
1
2017
75
0.030
 Why?
Recovery of Function
1
2018
203
0.030
 Why?
Methods
1
1996
53
0.030
 Why?
Equipment and Supplies
1
1996
16
0.030
 Why?
Hemodynamics
1
2018
236
0.030
 Why?
Internationality
1
2016
46
0.030
 Why?
Patient Readmission
1
2018
251
0.030
 Why?
Blood Transfusion
1
2016
127
0.030
 Why?
Intraoperative Complications
1
1996
114
0.030
 Why?
International Normalized Ratio
1
2014
29
0.030
 Why?
Ankle Brachial Index
1
2014
17
0.030
 Why?
Mobility Limitation
1
2014
27
0.030
 Why?
Animals
4
2002
13526
0.030
 Why?
Drug Resistance
1
2014
71
0.030
 Why?
Blood Pressure
2
2007
518
0.030
 Why?
Aryldialkylphosphatase
1
2013
6
0.030
 Why?
Sex Factors
2
2009
747
0.030
 Why?
Biotransformation
1
2013
84
0.030
 Why?
Exercise Test
1
2014
137
0.030
 Why?
Oxygen Consumption
1
2014
201
0.020
 Why?
Polymorphism, Genetic
1
2013
181
0.020
 Why?
Alleles
1
2013
277
0.020
 Why?
Adrenergic beta-1 Receptor Antagonists
1
2012
7
0.020
 Why?
Drug Antagonism
1
2012
8
0.020
 Why?
Child
1
2005
7379
0.020
 Why?
Embolic Protection Devices
1
2012
7
0.020
 Why?
Critical Pathways
1
2012
36
0.020
 Why?
Injections, Intravenous
1
2012
129
0.020
 Why?
Natriuretic Peptide, Brain
1
2011
32
0.020
 Why?
Models, Statistical
1
2012
229
0.020
 Why?
Kaplan-Meier Estimate
1
2011
487
0.020
 Why?
Cross-Over Studies
1
2011
241
0.020
 Why?
Cells, Cultured
1
2013
1569
0.020
 Why?
Femur Head
1
2009
26
0.020
 Why?
Probability
2
2001
171
0.020
 Why?
Confidence Intervals
1
2009
158
0.020
 Why?
Area Under Curve
1
2009
185
0.020
 Why?
Multiple Myeloma
1
2004
3082
0.020
 Why?
Hemorheology
1
2009
6
0.020
 Why?
Receptors, Thrombin
1
2009
14
0.020
 Why?
Adenosine Diphosphate
1
2009
20
0.020
 Why?
Polysaccharides
1
2009
57
0.020
 Why?
Linear Models
1
2009
287
0.020
 Why?
Cross-Sectional Studies
1
2014
1723
0.020
 Why?
Patient Education as Topic
1
2011
325
0.020
 Why?
Collagen
1
2009
215
0.020
 Why?
Ankle
1
2007
15
0.020
 Why?
Injections, Intramuscular
1
2007
55
0.020
 Why?
Brachial Artery
1
2007
18
0.020
 Why?
Calcium-Binding Proteins
1
2007
58
0.020
 Why?
Disease Progression
1
2010
880
0.020
 Why?
Heart Conduction System
1
2006
25
0.020
 Why?
Combined Modality Therapy
2
1999
640
0.020
 Why?
Sex Distribution
1
2006
140
0.020
 Why?
Age Distribution
1
2006
175
0.020
 Why?
Body Mass Index
1
2009
717
0.020
 Why?
Genetic Therapy
1
2007
127
0.020
 Why?
Insurance, Health
1
2006
146
0.010
 Why?
Ultrasonography, Interventional
1
2006
138
0.010
 Why?
Societies, Medical
1
2005
207
0.010
 Why?
Platelet Adhesiveness
1
2004
15
0.010
 Why?
Abnormalities, Multiple
1
2005
166
0.010
 Why?
Platelet Count
1
2004
68
0.010
 Why?
Vascular Endothelial Growth Factors
1
2003
15
0.010
 Why?
Adenoviridae
1
2003
46
0.010
 Why?
Injections, Subcutaneous
1
2003
55
0.010
 Why?
Smoking
1
2006
526
0.010
 Why?
Endpoint Determination
1
2002
27
0.010
 Why?
Vascular Endothelial Growth Factor A
1
2003
189
0.010
 Why?
Echocardiography
1
2005
409
0.010
 Why?
Instillation, Drug
1
2002
2
0.010
 Why?
Catheters, Indwelling
1
2001
56
0.010
 Why?
Angina Pectoris
1
2001
20
0.010
 Why?
Survival Analysis
1
2002
659
0.010
 Why?
Hypoglycemic Agents
1
2002
227
0.010
 Why?
District of Columbia
1
2000
21
0.010
 Why?
Insulin
1
2002
493
0.010
 Why?
Tunica Intima
1
2000
55
0.010
 Why?
Cineangiography
1
1999
9
0.010
 Why?
Prothrombin Time
1
1999
18
0.010
 Why?
Partial Thromboplastin Time
1
1999
15
0.010
 Why?
United States Food and Drug Administration
1
1999
93
0.010
 Why?
Radiographic Image Enhancement
1
1999
29
0.010
 Why?
Coronary Thrombosis
1
1999
22
0.010
 Why?
Coronary Circulation
1
1999
57
0.010
 Why?
Regional Blood Flow
1
1999
112
0.010
 Why?
Dogs
1
1999
186
0.010
 Why?
Radiotherapy, Adjuvant
1
1999
65
0.010
 Why?
Safety
1
1999
78
0.010
 Why?
Swine
1
2000
440
0.010
 Why?
Sensitivity and Specificity
1
2000
867
0.010
 Why?
Postoperative Care
1
1998
109
0.010
 Why?
Lipids
1
1998
163
0.010
 Why?
Disease Models, Animal
1
1999
1517
0.010
 Why?
Mice
1
1999
5982
0.000
 Why?
Saucedo's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (378) concept(s)
_
Co-Authors Expand Description
See all (4) people
_
Similar People Expand Description
See all (27) people
_
Same Department Expand Description
Search Department